Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$513M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 3 |
Meta Platforms (Facebook)
META
|
+$354M |
| 4 |
ServiceNow
NOW
|
+$262M |
| 5 |
American Airlines Group
AAL
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$571M |
| 2 |
Apple
AAPL
|
+$571M |
| 3 |
Netflix
NFLX
|
+$388M |
| 4 |
NVIDIA
NVDA
|
+$313M |
| 5 |
TSMC
TSM
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMTD
3376
AMTD IDEA Group
AMTD
$71.5M
| $14.5K | ﹤0.01% |
13,466
+2,900
| +27% | +$3.09K |
|
3377
SAB Biotherapeutics
SABS
$294M
| $13.6K | ﹤0.01% |
+10,030
| New | +$23K |
|
|
MYND
3378
Mynd.ai
MYND
$17.4M
| $13.5K | ﹤0.01% |
15,844
+400
| +3% | +$498 |
|
3379
Hyperfine
HYPR
$97.5M
| $13.1K | ﹤0.01% |
18,300
-194,000
| -91% | -$199K |
|
|
WLGS
3380
DELISTED
Wang & Lee Group
WLGS
| $12.9K | ﹤0.01% |
47,641
-13,159
| -22% | -$62.7K |
|
3381
CBL International Ltd
BANL
$8.36M
| $12.7K | ﹤0.01% |
+1,000
| New | +$14.4K |
|
3382
TDH Holdings
PETZ
$15.8M
| $12.7K | ﹤0.01% |
11,000
| – | – |
|
3383
TherapeuticsMD
TXMD
$24.2M
| $12.5K | ﹤0.01% |
13,500
+2,609
| +24% | +$2.6K |
|
3384
NextPlat
NXPL
$17.4M
| $12.1K | ﹤0.01% |
1,460
-1,340
| -48% | -$14K |
|
3385
China Pharma Holdings
CPHI
$49M
| $12.1K | ﹤0.01% |
+4,610
| New | +$10.5K |
|
|
LGMK
3386
DELISTED
LogicMark
LGMK
| $12.1K | ﹤0.01% |
+612,107
| New | +$422K |
|
3387
Matinas BioPharma
MTNB
$1.72M
| $11.6K | ﹤0.01% |
22,370
+4,200
| +23% | +$2.49K |
|
|
HYFT
3388
MindWalk Holdings
HYFT
$60.1M
| $11.1K | ﹤0.01% |
29,400
-48,800
| -62% | -$22K |
|
3389
Imunon
IMNN
$6.64M
| $11K | ﹤0.01% |
801
-1,772
| -69% | -$21.2K |
|
3390
TOMI Environmental Solutions
TOMZ
$14.2M
| $10.9K | ﹤0.01% |
+4,431
| New | +$12.5K |
|
3391
Mega Matrix
MPU
$14M
| $10.9K | ﹤0.01% |
+16,664
| New | +$15.6K |
|
3392
Acurx Pharmaceuticals
ACXP
$6.27M
| $10.4K | ﹤0.01% |
1,330
+596
| +81% | +$8.03K |
|
|
LGL.WS
3393
DELISTED
LGL Group Inc Warrants
LGL.WS
| $9.22K | ﹤0.01% |
28,823
-8,500
| -23% | -$2.27K |
|
3394
ALX Oncology
ALXO
$284M
| $8.91K | ﹤0.01% |
+14,299
| New | +$17.2K |
|
|
WORX
3395
DELISTED
SCWORX CORP NEW
WORX
| $7.7K | ﹤0.01% |
755
-618
| -45% | -$11.7K |
|
|
FAAS
3396
DELISTED
DigiAsia
FAAS
| $6.15K | ﹤0.01% |
+24,391
| New | +$14.2K |
|
3397
Talphera
TLPH
$74.2M
| $5.99K | ﹤0.01% |
12,100
-7,543
| -38% | -$4.6K |
|
|
HIND
3398
Vyome Holdings
HIND
$15M
| $5.88K | ﹤0.01% |
+163
| New | +$39K |
|
3399
IT Tech Packaging
ITP
$3.04M
| $5.82K | ﹤0.01% |
21,233
-11,185
| -35% | -$4.1K |
|
|
RTC
3400
DELISTED
Baijiayun Group
RTC
| $5.39K | ﹤0.01% |
+25,349
| New | +$24K |
|
Similar funds
Renaissance Technologies's Q1 2025 Portfolio in Review
As of Q1 2025, Renaissance Technologies held 3,989 positions worth $66.1B, down 2.2% from $67.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2025 filing shows 456 new, 1,472 increased, 1,441 reduced and 583 closed positions. Its largest new stake was ServiceNow: 1,361,505 shares worth $217M. The largest sale was Palantir, an estimated $571M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2025 buy was ServiceNow: 1,361,505 shares worth $217M.
- Renaissance Technologies added most to Broadcom in Q1 2025, an estimated $513M increase.
- Renaissance Technologies's biggest Q1 2025 reduction was Palantir, cutting an estimated $571M.
- Renaissance Technologies fully exited Nike in Q1 2025, selling an estimated $197M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.1B portfolio in Q1 2025.
- Renaissance Technologies opened 456 new positions and closed 583 in Q1 2025.
- Renaissance Technologies's portfolio value fell 2.2% quarter-over-quarter to $66.1B.
Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.